Adimmune Corp 4142
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- TWD 28.50
- Day Range
- TWD 26.80–28.45
- 52-Week Range
- TWD 25.00–41.15
- Bid/Ask
- TWD 27.30 / TWD 27.35
- Market Cap
- TWD 11.53 Bil
- Volume/Avg
- 2.1 Mil / 1.2 Mil
Key Statistics
- Price/Earnings (Normalized)
- 1,731.89
- Price/Sales
- 6.72
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Adimmune Corp is a Taiwan- based company. It is engaged in the manufacture and trade of vaccines , modern medicine products and testing reagents.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Growth
- Total Number of Employees
- 564
- Website
- https://www.adimmune.com.tw
Comparables
Valuation
|
Metric
|
4142
|
06891
|
6183
|
|---|---|---|---|
Price/Earnings (Normalized) | 1,731.89 | — | 23.23 |
Price/Book Value | 2.19 | 2.99 | 4.27 |
Price/Sales | 6.72 | — | 4.84 |
Price/Cash Flow | — | — | 18.00 |
Price/Earnings
4142
06891
6183
Financial Strength
|
Metric
|
4142
|
06891
|
6183
|
|---|---|---|---|
Quick Ratio | 2.12 | 63.77 | 2.40 |
Current Ratio | 2.63 | 64.05 | 2.47 |
Interest Coverage | −22.58 | −102.74 | 694.46 |
Quick Ratio
4142
06891
6183
Profitability
|
Metric
|
4142
|
06891
|
6183
|
|---|---|---|---|
Return on Assets (Normalized) | −3.83% | −4.48% | 13.71% |
Return on Equity (Normalized) | −6.10% | −4.68% | 19.04% |
Return on Invested Capital (Normalized) | −3.83% | −6.29% | 18.14% |
Return on Assets
4142
06891
6183
Biotechnology Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
NVO
| Novo Nordisk A/S ADR | Txfhtxjvk | Cwykw | $550.4 Bil | |
VRTX
| Vertex Pharmaceuticals Inc | Tjwnnmj | Vpcwmh | $101.7 Bil | |
REGN
| Regeneron Pharmaceuticals Inc | Jydntfzvq | Bltbq | $98.1 Bil | |
MRNA
| Moderna Inc | Fmxcrqh | Qlcnh | $39.1 Bil | |
ARGX
| argenx SE ADR | Gyxfvrtf | Ztmjh | $21.7 Bil | |
BNTX
| BioNTech SE ADR | Gdtsyjv | Jjv | $20.8 Bil | |
ALNY
| Alnylam Pharmaceuticals Inc | Xfcbnjgd | Jltcfq | $18.4 Bil | |
BMRN
| Biomarin Pharmaceutical Inc | Rvqfphcl | Tthkg | $17.1 Bil | |
RPRX
| Royalty Pharma PLC Class A | Qcgcfltbh | Sntbtr | $12.5 Bil | |
INCY
| Incyte Corp | Fyfhxlmwg | Qvkknw | $11.9 Bil |